These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome].
    Author: Suzuki J, Matsubuchi S, Yoshihara E, Kobayashi S, Okamura K, Okuda T, Okazaki M, Furuya N, Uchimura H, Tokunaga T, Shimazaki S.
    Journal: Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877.
    Abstract:
    Extracellular products of group A streptococci isolated from patients with streptococcal toxic shock syndrome (STSS) were examined. The outline of the discussion of the 3 products are as follows; streptolysin O (SLO), proteinase and erythrogenic toxin. SLO and proteinase showed a relatively large amount of products more than erythrogenic toxin. SLO produced by group A streptococci isolated from the patient with STSS had an isoelectric point (pI) of 6.0 and a molecular weight of 64,000 and showed hemolytic activity in the presence of 2-mercaptoethanol (2-ME). Furthermore, the hemolytic activities of all components were inhibited by gamma-globulin and cholesterol. Proteinase had pIs of 8.7 and 8.9, and a molecular weight of 21,000. These data suggest that STSS clinical criteria probably reflects a characteristic of a large amount of products of individual S. pyogenes isolates.
    [Abstract] [Full Text] [Related] [New Search]